Equities

Nightingale Health Oyj

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Nightingale Health Oyj

Actions
  • Price (EUR)1.51
  • Today's Change-0.064 / -4.08%
  • Shares traded1.00k
  • 1 Year change-45.63%
  • Beta1.2295
Data delayed at least 15 minutes, as of Feb 06 2026 07:04 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nightingale Health Oyj is a Finland-based health technology company whose mission is to build sustainable healthcare and reduce health inequalities. It has developed an advanced health check that provides risk detection for multiple chronic diseases from a single blood sample. The blood analysis technology developed by Nightingale measures a broad group of biomarkers from a single blood sample, recognizing individual disease risks. The Company provides people with comprehensive insights on health, helps them make better decisions regarding their health and connects them with healthcare experts that offer preventative services for maintaining health. Nightingale Health Oy is the Parent Company in the Nightingale Group. The Company has subsidiaries in the United Kingdom, Japan, Sweden, Germany, Singapore, Estonia and the United States.

  • Revenue in EUR (TTM)4.69m
  • Net income in EUR-18.46m
  • Incorporated2002
  • Employees100.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.